Stefan Vitorovic - Jan 6, 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role: Director
Signature: /s/ Jennifer Ziolkowski, Attorney-in-Fact
Stock symbol: VIGL
Transactions as of: Jan 6, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/6/2022, 07:54 PM
Previous filing: Jun 9, 2021
Next filing: Jan 11, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VIGL	Series B Preferred Stock							Jan 6, 2022	Common Stock	3.33M		By Vida Ventures III, L.P.	F1, F2
holding	VIGL	Series B Preferred Stock							Jan 6, 2022	Common Stock	7.68K		By Vida Ventures III-A, L.P.	F1, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of Series B Preferred Stock are convertible into Common Stock on a one-for-2.7732 basis at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date.
F2	The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of of Vida III. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III, except to the extent of his pecuniary interest therein, if any.
F3	The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of of Vida III-A. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III-A, except to the extent of his pecuniary interest therein, if any.

Remarks:

Exhibit 24 - Power of Attorney